Chromocell Therapeutics's other assets is $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Chromocell Therapeutics (CHRO) currently reports a other assets of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Chromocell Therapeutics's other assets history and peer comparisons.
Chromocell Therapeutics's other assets changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Chromocell Therapeutics reported $0 in other assets as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Chromocell Therapeutics, and consider following CHRO for alerts when major investors trade the stock.